Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Update

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSCGet Free Report) saw a significant growth in short interest in August. As of August 14th, there was short interest totaling 14,573 shares, a growth of 211.9% from the July 30th total of 4,673 shares. Based on an average trading volume of 4,750 shares, the short-interest ratio is presently 3.1 days. Approximately 0.0% of the shares of the stock are short sold.

Cardiac Biotech Solutions Stock Performance

CBSC remained flat at $0.04 during trading on Friday. Cardiac Biotech Solutions has a fifty-two week low of $0.02 and a fifty-two week high of $0.06. The business has a 50 day moving average of $0.03 and a 200-day moving average of $0.04.

About Cardiac Biotech Solutions

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

See Also

Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.